Clinical Data of Patients With Hemangioblastomas and Glioblastomas
| Lane No./Diagnosis . | Age (yr)/ Sex . | Tumor Location . | Hemoglobin (g/L) . | Hematocrit (%) . | VHL Syndrome . |
|---|---|---|---|---|---|
| 3/Hemangioblastoma | 45/M | Cerebellum | NA | NA | Yes-150 |
| 4/Hemangioblastoma | 25/F | Cerebellum | NA | NA | No |
| 5/Hemangioblastoma | 38/F | Cerebellum | 14.8 | 43.3 | No |
| 6/Hemangioblastoma | 56/M | Spinal | 13.1 | 39.9 | No-151 |
| 7/Hemangioblastoma | 26/F | Cerebellum | 14.8 | 45.9 | Yes |
| 8/Glioblastoma | 70/F | Temporal | 12.2 | 37.2 | No |
| 9/Glioblastoma | 72/F | Parietal | 12.1 | 36.9 | No |
| 12/Hemangioblastoma | 40/M | Cerebellum | 14.6 | 42.1 | Yes |
| 13/Hemangioblastoma | 24/M | Medulla | 14.6 | 42.9 | Yes |
| 14/Hemangioblastoma | 34/F | Cerebellum | 11.8 | 37.6 | Yes |
| 15/Hemangioblastoma | 44/F | Cerebellum | 16.2 | 47.7 | No |
| 16/Hemangioblastoma | 19/M | Cerebellum | 15.7 | 45.5 | Yes |
| 17/Hemangioblastoma | 49/M | Cerebellum | 16.5 | 48.5 | Yes-150 |
| 18/Glioblastoma | 37/F | Parietal | 14.1 | 41.6 | No |
| 19/Glioblastoma | 61/M | Occipital | 13.8 | 41.0 | No |
| Lane No./Diagnosis . | Age (yr)/ Sex . | Tumor Location . | Hemoglobin (g/L) . | Hematocrit (%) . | VHL Syndrome . |
|---|---|---|---|---|---|
| 3/Hemangioblastoma | 45/M | Cerebellum | NA | NA | Yes-150 |
| 4/Hemangioblastoma | 25/F | Cerebellum | NA | NA | No |
| 5/Hemangioblastoma | 38/F | Cerebellum | 14.8 | 43.3 | No |
| 6/Hemangioblastoma | 56/M | Spinal | 13.1 | 39.9 | No-151 |
| 7/Hemangioblastoma | 26/F | Cerebellum | 14.8 | 45.9 | Yes |
| 8/Glioblastoma | 70/F | Temporal | 12.2 | 37.2 | No |
| 9/Glioblastoma | 72/F | Parietal | 12.1 | 36.9 | No |
| 12/Hemangioblastoma | 40/M | Cerebellum | 14.6 | 42.1 | Yes |
| 13/Hemangioblastoma | 24/M | Medulla | 14.6 | 42.9 | Yes |
| 14/Hemangioblastoma | 34/F | Cerebellum | 11.8 | 37.6 | Yes |
| 15/Hemangioblastoma | 44/F | Cerebellum | 16.2 | 47.7 | No |
| 16/Hemangioblastoma | 19/M | Cerebellum | 15.7 | 45.5 | Yes |
| 17/Hemangioblastoma | 49/M | Cerebellum | 16.5 | 48.5 | Yes-150 |
| 18/Glioblastoma | 37/F | Parietal | 14.1 | 41.6 | No |
| 19/Glioblastoma | 61/M | Occipital | 13.8 | 41.0 | No |
Lane numbers refer to Fig 1. All hemoglobin and hematocrit values represent measurements prior to tumor resection. The diagnosis of VHL syndrome is based on clinical data alone.
Abbreviations: F, female; M, male; NA, not available.
Patient with multiple cerebellar hemangioblastomas with surgery at 2 different time points.
Patient with recurrent spinal hemangioblastomas but no other stigmata of VHL syndrome.